** Shares of Cyclopharm up 17.2% at A$2.38
** Stock rises as much as 23.2% to A$2.5 in early trade, hitting its highest level since Oct 16, 2023
** Radiopharmaceutical firm signs contract with healthcare provider Hospital Corporation of America Healthcare $(HCA)$
** Says contract for deployment of co's Technegas imaging technology in up to 169 nuclear medicine departments across HCA'S network
** Co did not provide any transactional details regarding contract
** Technegas imaging technology is used to detect pulmonary embolism
** More than 502,000 shares change hands, 5.8 times the 30-day avg
** Cyclopahrm up 49.5% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.